Skip to main content

Proceeding contribution from Alan Johnson (Labour) in the House of Commons on Monday, 12 May 2008. It occurred during Debate on bill on Human Fertilisation and Embryology Bill.


Human Fertilisation and Embryology Bill

I accept my hon. Friend's point. Thankfully, modern drugs ensure that not so many eggs are produced in IVF, and to a certain extent, that is why the problem has arisen. The Bill introduces explicit regulations on embryo screening. Embryo screening and selection will be allowed only for the purpose of detecting serious genetic diseases or disorders. The Human Fertilisation and Embryology Authority has licensed screening in a number of cases since 1990, including for single-gene disorders such as muscular dystrophy and sickle cell disease. The Bill will clarify the powers of the HFEA to license embryo screening to enable parents to have a child who is a genetic match for an older brother or sister who is seriously ill. That has been permitted by the HFEA in a handful of cases as a last resort, where there are no other donors and all other medical avenues have been exhausted.


Secondary information

Type
Proceeding contribution
Reference
475 c1069 
Session
2007-08
Chamber / Committee
House of Commons chamber
Subjects
Civil partnerships Clones Abortion Blood Fertility Human embryo experiments Diseases Donors Genetics Human Fertilisation and Embryology Authority Ethics IVF Discrimination Foetal tissue NHS Medical treatments Screening Religion Sexuality Research Stem cells Christianity Human-animal hybrid embryos
Legislation
Human Fertilisation and Embryology Bill (HL) 2007-08
Link
View this Proceeding contribution on www.publications.parliament.uk